USAntibiotics
Eric Wesoloski has extensive experience in quality assurance, regulatory affairs, and pharmacovigilance within the pharmaceutical industry. Currently serving as the VP of Quality, Regulatory Affairs, and Pharmacovigilance at USAntibiotics, Eric has held key leadership roles including Senior Director of Quality at TransCode Therapeutics, Inc., Executive Director of Quality at Regor Therapeutics Group, and Vice President of Global Quality Assurance at Gan & Lee Pharmaceuticals. Additionally, Eric's background includes a position as Deputy Director of Quality Risk and Performance at Sanofi Pasteur, showcasing a strong foundation in managing quality standards and regulatory compliance across various organizations.
This person is not in any teams
This person is not in any offices
USAntibiotics
USAntibiotics is the only U.S. manufacturer of Amoxicillin and Amoxicillin Clavulanate, commonly known as Amoxil and Augmentin. Based in Bristol, Tennessee, it operates a world-class, 394,000-square-foot antibiotic production facility with the sole focus of making quality, life-saving antibiotics widely available for the benefit of all Americans.